Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma

Author： Brown Joshua D.   Adams Val R.   Moga Daniela C.  

Publisher： MDPI

E-ISSN： 2227-9032|4|4|93-93

ISSN： 2227-9032

Source： Healthcare, Vol.4, Iss.4, 2016-12, pp. : 93-93

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies

By Brown Joshua D.   Adams Val R.  

Healthcare, Vol. 4, Iss. 1, 2016-02 ,pp. : 16-16

MDPI

Access to resources Recommend Favorite

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

By Merin Noah M.   Kelly Kevin R.  

Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. : 1-20

MDPI

Access to resources Recommend Favorite

The Role of Immunotherapy in Multiple Myeloma

By Kocoglu Mehmet   Badros Ashraf  

Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures

By Catania Gioacchino   Monaco Federico   Limberti Giulia   Alessio Manuela   De Martino Iolanda   Barile Cecilia   Fasciolo Antonella   Baraldi Anna   Ladetto Marco   Fusco Vittorio  

Dentistry Journal, Vol. 4, Iss. 4, 2016-12 ,pp. : 45-45

MDPI

Access to resources Recommend Favorite

Development of Novel Immunotherapies for Multiple Myeloma

By Al-Hujaily Ensaf M.   Oldham Robyn A. A.   Hari Parameswaran   Medin Jeffrey A.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1506-1506

MDPI

Access to resources Recommend Favorite